Drug maker sought sales increase despite evidence

You are here: Planet Chiropractic > News > Article

Serving Chiropractors Worldwide

Chiropractic Jobs | Practices for Sale | Employment | Billing Services

Search:

Posted on: Monday, September 20, 1999

Drug maker sought sales increase despite evidence
Dr. Mike

DALLAS (AP) -- Despite growing evidence that a link existed between the diet drugs fen-phen and fatal lung disease and heart damage, a maker of one of the drugs lobbied the government to relax limits on its use, The Dallas Morning News reported Monday.
Internal company memos in 1996 indicated that American Home Products knew of illnesses and deaths from the rare lung disease among users of Pondimin, which was part of the fen-phen diet-drug combination, the report said.
In 1997 the company received researchers' reports of leaky heart valves among fen-phen users, according to the newspaper.
At the same time, the newspaper reported, the Madison, N.J.-based company and its pharmaceutical division, Wyeth-Ayerst Laboratories, lobbied members of Congress and the U.S. Drug Enforcement Administration to ease restrictions on use of Pondimin and Redux.
Click here for entire article

Subscribe RSS:

E-mail newsletters

Search:

Select Featured Articles

Chiropractic Los Angeles:
What it's like

Featured Article - Chiropractor Salaries

Assessing
Chiropractor Salaries

Pregnancy &
Chiropractic

Estrogen, Hormones,
Osteoporosis and Bones

Copyright © 2000 - 2012 Planet Chiropractic. All rights reserved. The content (including but not limited to text, photo,
multimedia information, etc) published on this site belongs to Planet Chiropractic (planetc1,LLC). Without written
authorization from planetc1,LLC, such content shall not be republished or used in any form.
Questions or Comments - Privacy Policy - Terms of Service